Benzinga's M&A Chatter for Wednesday January 18, 2012

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday January 18, 2012: E*Trade Financial to be Acquired The Rumor:
E*Trade Financial ETFC to be acquired by a combination of companies, according to sources. E*Trade last had takeover chatter back on October 24, 2011 and on November 10, announced it was ending plans to sell itself. An E*Trade spokesperson was not available for comment. E*Trade closed at $9.36 Wednesday, a gain of 1.74% for the day on 65% of the average daily volume. Private Equity to Acquire Crocs The Rumor:
Crocs CROX to be acquired by private equity according to sources. The price being discussed is around $25.00 per share. Crocs did not respond to calls from Benzinga. Crocs closed at $18.79 Wednesday, a gain of 3.98% for the day on 1.32 times the average daily volume. Merck, Johnson & Johnson to Acquire Vertex Pharmaceuticals The Rumor:
Vertex Pharmaceuticals VRTX has hired Goldman Sachs to handle the bidding process. Interested buyers include Merck and Johnson & Johnson. The rumored asking pice is $55 per share. That price is in the same range as analysts price targets for the stock in early December. Vertex closed at $37.47 Wednesday, a gain of 2.63% for the day on 1.32 times the average daily volume. Merck, Johnson & Johnson, Abbott Labs to Acquire Idenix Pharmaceuticals The Rumor:
Merck MRK, Johnson & Johnson JNJ or Abbott Labs ABT will acquire Idenix Pharmaceuticals IDIX, according to comments out of Wedbush. The takeover target price will be around $24 per share. Idenix has had a tremendous run over the past week to 10 days, as part of the hepatitis C 'bubble', rising 100%. Competitor Inhibitex recently agreed to be acquired by Bristol-Myers Squibb for $26 per share. Idenix Pharmaceuticals closed at $14.48 Wednesday, a gain of 6.20% for the day on almost twice the average daily volume.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsShort IdeasRumorsM&AAfter-Hours CenterMoversTechTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!